These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 14634141)
1. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo. Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141 [TBL] [Abstract][Full Text] [Related]
2. The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1 and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo. Li N; Park M; Zhao M; Hilario-Vargas J; McInnes DM; Prisayanh PS; Liu Z; Diaz LA J Invest Dermatol; 2010 Dec; 130(12):2773-80. PubMed ID: 20631728 [TBL] [Abstract][Full Text] [Related]
3. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering. Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. Amagai M; Hashimoto T; Green KJ; Shimizu N; Nishikawa T J Invest Dermatol; 1995 Jun; 104(6):895-901. PubMed ID: 7539469 [TBL] [Abstract][Full Text] [Related]
5. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
6. Desmoglein-1 is a minor autoantigen in dogs with pemphigus foliaceus. Olivry T; LaVoy A; Dunston SM; Brown RS; Lennon EM; Warren SJ; Prisayanh P; Müller EJ; Suter MM; Dean GA Vet Immunol Immunopathol; 2006 Apr; 110(3-4):245-55. PubMed ID: 16293316 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice. Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524 [TBL] [Abstract][Full Text] [Related]
8. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446 [TBL] [Abstract][Full Text] [Related]
9. 230-kDa and 190-kDa proteins in addition to desmoglein 1 as immunological targets in a subset of pemphigus foliaceus with a combined cell-surface and basement membrane zone immune staining pattern. Karlhofer FM; Hashimoto T; Slupetzky K; Kiss M; Liu Y; Amagai M; Pieczkowski F; Foedinger D; Kirnbauer R; Stingl G Exp Dermatol; 2003 Oct; 12(5):646-54. PubMed ID: 14705806 [TBL] [Abstract][Full Text] [Related]
10. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765 [TBL] [Abstract][Full Text] [Related]
11. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390 [TBL] [Abstract][Full Text] [Related]
12. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. Koulu L; Kusumi A; Steinberg MS; Klaus-Kovtun V; Stanley JR J Exp Med; 1984 Nov; 160(5):1509-18. PubMed ID: 6491602 [TBL] [Abstract][Full Text] [Related]
13. Protection against pemphigus foliaceus by desmoglein 3 in neonates. Wu H; Wang ZH; Yan A; Lyle S; Fakharzadeh S; Wahl JK; Wheelock MJ; Ishikawa H; Uitto J; Amagai M; Stanley JR N Engl J Med; 2000 Jul; 343(1):31-5. PubMed ID: 10882766 [No Abstract] [Full Text] [Related]
14. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185 [TBL] [Abstract][Full Text] [Related]
15. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study. Zhou S; Ferguson DJ; Allen J; Wojnarowska F Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820 [TBL] [Abstract][Full Text] [Related]
16. Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus. Sami N; Bhol KC; Ahmed AR Clin Immunol; 2002 Nov; 105(2):192-8. PubMed ID: 12482393 [TBL] [Abstract][Full Text] [Related]
17. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. Aoyama Y; Tsujimura Y; Funabashi M; Sato M; Kamiya H; Kitajima Y Eur J Dermatol; 2000; 10(1):18-21. PubMed ID: 10694292 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. Li N; Zhao M; Wang J; Liu Z; Diaz LA J Immunol; 2009 Jan; 182(1):711-7. PubMed ID: 19109205 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of acantholysis in pemphigus foliaceus. España A; Diaz LA; Mascaró JM; Giudice GJ; Fairley JA; Till GO; Liu Z Clin Immunol Immunopathol; 1997 Oct; 85(1):83-9. PubMed ID: 9325073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]